Allovir Inc ALVR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:56 PM EDT
0.79quote price arrow down-0.0058 (-0.7333%)
Volume
2,154
Close
0.7909quote price arrow up+0.0279 (+3.6566%)
Volume
278,249
52 week range
0.62 - 6.12
Loading...
  • Open0.76
  • Day High0.825
  • Day Low0.76
  • Prev Close0.763
  • 52 Week High6.12
  • 52 Week High Date06/07/23
  • 52 Week Low0.62
  • 52 Week Low Date01/04/24

Key Stats

  • Market Cap90.213M
  • Shares Out114.06M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change16.34

KEY STATS

  • Open0.76
  • Day High0.825
  • Day Low0.76
  • Prev Close0.763
  • 52 Week High6.12
  • 52 Week High Date06/07/23
  • 52 Week Low0.62
  • 52 Week Low Date01/04/24
  • Market Cap90.213M
  • Shares Out114.06M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change16.34

RATIOS/PROFITABILITY

  • EPS (TTM)-1.83
  • P/E (TTM)-0.43
  • Fwd P/E (NTM)-1.99
  • EBITDA (TTM)-180.934M
  • ROE (TTM)-75.29%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Allovir Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. Its technology and manufacturing...
David Hallal
Executive Chairman of the Board
Diana Brainard M.D.
Chief Executive Officer, Director
Vikas Sinha CPA
President, Chief Financial Officer, Director
Brett Hagen
Chief Accounting Officer
Edward Miller J.D.
General Counsel, Secretary
Address
1100 Winter Street
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
ELTX
Elicio Therapeutics Inc
9.22-0.52-5.34%
SLS
Sellas Life Sciences Group Inc
1.63+0.09+5.84%
RVPH
Reviva Pharmaceuticals Holdings, Inc.
3.06-0.03-0.97%
CVM
CEL-SCI Corp
1.47-0.04-2.65%
JSPR
Jasper Therapeutics Inc
22.11-0.41-1.82%